Trial
NCT06657885
CAbotégravir LENacapavir DUal Long Acting
Phase IIWITHDRAWNEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Collaborators
ANRS, Emerging Infectious Diseases
Condition
HIV1 Infection
Intervention
his is a prospective, single-arm, multicentre, non-randomised phase II, pilot study designed to achieve or maintain virological success in participants who meet the prescribing criteria for lenacapavi
Why stopped
No response regarding coverage of treatments by social security and the DGOS
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-14